CAD4.02
0.74% day before yesterday
Toronto, Dec 27, 10:00 pm CET
ISIN
CA1380351009
Symbol
WEED

Canopy Growth Corporation Stock price

CAD4.02
-1.45 26.51% 1M
-5.14 56.11% 6M
-2.74 40.53% YTD
-2.88 41.74% 1Y
-121.38 96.79% 3Y
-247.08 98.40% 5Y
-16.28 80.20% 10Y
Toronto, Closing price Fri, Dec 27 2024
-0.03 0.74%
ISIN
CA1380351009
Symbol
WEED

Key metrics

Market capitalization CAD396.67m
Enterprise Value CAD771.48m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.75
P/S ratio (TTM) P/S ratio 1.41
P/B ratio (TTM) P/B ratio 0.74
Revenue growth (TTM) Revenue growth -20.59%
Revenue (TTM) Revenue CAD280.50m
EBIT (operating result TTM) EBIT CAD-101.21m
Free Cash Flow (TTM) Free Cash Flow CAD-167.58m
Cash position CAD238.71m
EPS (TTM) EPS CAD-6.73
P/E forward negative
P/S forward 1.45
EV/Sales forward 2.82
Short interest 2.39%
Show more

Is Canopy Growth Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Canopy Growth Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Canopy Growth Corporation forecast:

1x Buy
11%
4x Hold
44%
4x Sell
44%

Analyst Opinions

9 Analysts have issued a Canopy Growth Corporation forecast:

Buy
11%
Hold
44%
Sell
44%

Financial data from Canopy Growth Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
281 281
21% 21%
100%
- Direct Costs 218 218
42% 42%
78%
62 62
407% 407%
22%
- Selling and Administrative Expenses 119 119
51% 51%
42%
- Research and Development Expense - -
-
-
-56 -56
80% 80%
-20%
- Depreciation and Amortization 45 45
38% 38%
16%
EBIT (Operating Income) EBIT -101 -101
71% 71%
-36%
Net Profit -565 -565
57% 57%
-201%

In millions CAD.

Don't miss a Thing! We will send you all news about Canopy Growth Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Head office Canada
CEO David Klein
Employees 1,029
Founded 2009
Website www.canopygrowth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today